2nd International Conference on Translational Medicine

Chicago, IL, November 02, 2012 --(PR.com)-- We do think of translational research and drug discovery as a one-way street. It all starts with the identification of a molecular mechanism and later on eventually leading to a drug that can specifically target a component. 2nd International Conference on Translational Medicine (Translational Medicine-2013) provides introduction to the emerging field of Translational Medicine. Translational Medicine plays an important role in research and pharmaceutical industry. It can be defined in terms of promoting multidisciplinary interactions between science and medicine to enhance disease research and drug development.This conference also covers the driving forces behind the development of Translational Medicine and its impact in meshing together advances in science and medicine.

The Editors of Journal of Translational Medicine and Journal of Clinical Trials are jointly organizing this event. The program is currently evolving through collaboration between local and international experts and is expected to be very innovative.

Translational Medicine-2013 will cover current and emerging challenges in the biopharmaceutical industry and strategies for drug development. Current strategies and processes for drug discovery and development within the pharmaceutical industry are contrasted with the adoption of Translational Medicine research strategies. Translational Medicine-2013 considers the requirements of various medical advances in terms of innovative strategic approaches to deliver advances to patients, and the contrasting requirements for effective translation in commercial companies and health services. It will cover integration across scientific, medical and socio-economic disciplines.

The conference specially emphasizes on:

· Molecular Biology in Translational Research
· Biomarkers in Translational Medicine
· Pharmaco Genomic Testing in Current Clinical Practice
· Diseases Treated with Targeted Molecular Therapy
· Translational Modeling of Efficacy & Safety
· Clinical Epidemiology
· Translation of Animal Models to the Clinic
· Tumor Biobanks in Translational Medicine
· Advances in Translational Medicine